Medicis deal

Medicis Pharmaceutical Corp. (MDRXA) Medicis Pharmaceutical Corp. (MDRXA) has acquired a 75 percent interest in Genetic MediSyn Corp., which has patented the enzyme believed to be a major factor in t...